During the past decade, American Fork Hospital / Huntsman Intermountain Cancer Center conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 38 clinical trials were completed, i.e. on average, 52.1% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 27 clinical trials were completed. i.e. 158.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "American Fork Hospital / Huntsman Intermountain Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "American Fork Hospital / Huntsman Intermountain Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "American Fork Hospital / Huntsman Intermountain Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Carcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials) and "HER2/Neu Negative" (4 trials). Many other conditions were trialed in "American Fork Hospital / Huntsman Intermountain Cancer Center" in a lesser frequency.

Most popular intervention types in "American Fork Hospital / Huntsman Intermountain Cancer Center" are "Other" (81 trials), "Drug" (77 trials), "Biological" (46 trials), "Procedure" (32 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (35 trials), "Questionnaire Administration" (19 trials), "Biospecimen Collection" (15 trials) and "Computed Tomography" (15 trials). Other intervention names were less common.

The vast majority of trials in "American Fork Hospital / Huntsman Intermountain Cancer Center" are 80 trials for "All" genders, 21 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "American Fork Hospital / Huntsman Intermountain Cancer Center". undefined are not yet recruiting, 19 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in American Fork Hospital / Huntsman Intermountain Cancer Center, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in American Fork Hospital / Huntsman Intermountain Cancer Center, 2 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".